1.3D-printed titanium implant with pre-mounted dental implants for mandible reconstruction: a case report
Jung-Hyun PARK ; Michidgerel ODKHUU ; Sura CHO ; Jingwen LI ; Bo-Young PARK ; Jin-Woo KIM
Maxillofacial Plastic and Reconstructive Surgery 2020;42(1):28-
Background:
This clinical case presented a novel method of segmental mandible reconstruction using 3D-printed titanium implant with pre-mounted dental implants that was planned to rehabilitate occlusion.Case presentationA 53-year-old male who suffered osteoradionecrosis due to the radiation after squamous cell carcinoma resection. The 3D-printed titanium implant with pre-mounted dental implant fixtures was simulated and fabricated with selective laser melting method. The implant was successfully inserted, and the discontinuous mandible defect was rehabilitated without postoperative infection or foreign body reaction during follow-ups, until a year.
Conclusions
The 3D-printed titanium implant would be the one of the suitable treatment modalities for mandible reconstruction considering all the aspect of mandibular functions.
2.3D-printed titanium implant with pre-mounted dental implants for mandible reconstruction: a case report
Jung-Hyun PARK ; Michidgerel ODKHUU ; Sura CHO ; Jingwen LI ; Bo-Young PARK ; Jin-Woo KIM
Maxillofacial Plastic and Reconstructive Surgery 2020;42(1):28-
Background:
This clinical case presented a novel method of segmental mandible reconstruction using 3D-printed titanium implant with pre-mounted dental implants that was planned to rehabilitate occlusion.Case presentationA 53-year-old male who suffered osteoradionecrosis due to the radiation after squamous cell carcinoma resection. The 3D-printed titanium implant with pre-mounted dental implant fixtures was simulated and fabricated with selective laser melting method. The implant was successfully inserted, and the discontinuous mandible defect was rehabilitated without postoperative infection or foreign body reaction during follow-ups, until a year.
Conclusions
The 3D-printed titanium implant would be the one of the suitable treatment modalities for mandible reconstruction considering all the aspect of mandibular functions.
3.Anti-inflammatory Effects of Ampelopsis Japonica Root on Contact Dermatitis in Mice.
Yoona OH ; Hongbum LEE ; Beodeul YANG ; Sura KIM ; Hyunwoo JEONG ; Hyungwoo KIM
Chinese journal of integrative medicine 2022;28(8):719-724
OBJECTIVE:
To investigate the anti-inflammatory potential of Ampelopsis japonica on contact dermatitis (CD).
METHODS:
A total of 38 Balb/c mice were divided into 5 groups by using a random number table: normal mice (n=6), CD model mice (n=8), CD mice treated with 3 or 30 mg/kg of the ethanol extract of A. japonica (EEAJ, n=8) and 7.5 mg/kg dexamethasone treated CD mice (DEX, n=8). CD was induced using topical application of 1-fluoro-2,4-dinitrofluorobenzene in mice. EEAJ and DEX were topically applied to the shaved skin of each mouse for 6 days, and the effects of EEAJ and DEX on skin lesions and color, histopathological abnormalities such as epidermal hyperplasia and immune cell infiltration, and tumor necrosis factor (TNF)-α, interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1) production were investigated. The effects on changes in body weights and spleen/body weight ratio were also investigated.
RESULTS:
EEAJ at 30 mg/kg significantly prevented scaling, erythema and enlargement of skin weight compared to using carbon dioxide. EEAJ also prevented epithelial hyperplasia and immune cell infiltrations induced by repeated application of DNFB (P<0.01). In addition, EEAJ significantly lowered levels of TNF-α, IL-6 and MCP-1 (P<0.05 or P<0.01). The anti-inflammatory effects of EEAJ were similar to those of DEX.
CONCLUSION
A. japonica may be a new therapeutic agent with the potential to reduce or replace corticosteroids and its mechanisms are closely related to regulation of TNF-α production.
Ampelopsis
;
Animals
;
Anti-Inflammatory Agents/therapeutic use*
;
Cytokines
;
Dermatitis, Contact/pathology*
;
Dinitrofluorobenzene/therapeutic use*
;
Hyperplasia/drug therapy*
;
Interleukin-6
;
Mice
;
Mice, Inbred BALB C
;
Plant Extracts/therapeutic use*
;
Tumor Necrosis Factor-alpha